Empowering Patients and Prescribers to Improve Treatment Adherence in Schizophrenia
Introduction
Hospitalization Rate Meta-Analysis Long-Acting Injectables vs Oral Antipsychotic
Swedish Registry: Mortality Risk LAIs and Oral Antipsychotics
Recent Online Survey Persons With Lived Experience and Caretakers
Psychiatrists Attitudes Long-Acting Injectables
Real-World Data: PRELAPSE Trial
Real-World Data: PRELAPSE Trial Findings
LAI Antipsychotics Second-Generation Agents
Understanding Adverse Event History Expert Consensus Survey
LAI Antipsychotics First-Generation Dosing Overview
LAI Characteristics and Properties Prescribing Considerations
FDA-Approved LAIs for Schizophrenia Characteristics of First- and Second-Generation LAIs
Discussing LAI Options: Considering the Experience of the Person With Lived Experience and Their Family
LAI Selection Factors Expert Consensus Survey
Summary of Recommendations Expert Consensus Survey
Shared Decision Making
Patient Preference Discussion Considering an LAI
Multidisciplinary Team Needs to Be Aligned
Multidisciplinary Team Education
Concise Communication and Education
Use of LAIs Clinical Insights
Evolution of Opinions Who Are Candidates for LAI Antipsychotics?
Concluding Remarks
Lived Experience With Schizophrenia Q&A
Can you tell us what is the most difficult or frustrating aspect of managing your experience with schizophrenia?
Was there anything regarding treatment that was problematic and would be best to avoid?
What is it like to take medications for schizophrenia?
Can you talk about your experience with long acting, injectable medication?
What has been the most difficult aspect of treatment for you?
How did you get help with this aspect?
Was there anyone in particular on the team that was able to help?
How were they able to help? What did they do?
Other than medications, what did you find helpful?
What advice would you like to give to providers?
What is the best way to include family?
What is the best way to include members of the treatment team?
Abbreviations